Isolation of Brucella melitensis from a patient with hearing loss.
Valenza
G
G
Institute of Hygiene and Microbiology, University of Würzburg, Josef-Schneider-Strasse 2, 97080 Würzburg, Germany. gvalenza@hygiene.uni-wuerzburg.de
Kallmann
B
B
Berend
A
A
Mlynski
R
R
Nöckler
K
K
Kurzai
O
O
Frosch
M
M
Abele-Horn
M
M
D000328:Adult; D000372:Agglutination Tests / Q000379:methods; D000818:Animals; D000900:Anti-Bacterial Agents / Q000008:administration & dosage; D000907:Antibodies, Bacterial / Q000097:blood; D017347:Brucella melitensis / Q000235:genetics / Q000276:immunology / Q000302:isolation & purification*; D002006:Brucellosis / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology; D004269:DNA, Bacterial / Q000737:chemistry; D004318:Doxycycline / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D006319:Hearing Loss, Sensorineural / Q000209:etiology*; D006801:Humans; D008297:Male; D012336:RNA, Ribosomal, 16S / Q000235:genetics; D012293:Rifampin / Q000008:administration & dosage; D000160:Vestibulocochlear Nerve Diseases / Q000150:complications* / Q000175:diagnosis / Q000382:microbiology; D015047:Zoonoses
D000900:Anti-Bacterial Agents; D000907:Antibodies, Bacterial; D004269:DNA, Bacterial; D012336:RNA, Ribosomal, 16S; D004318:Doxycycline; D012293:Rifampin